Quality & Patient Safety

FDA and Wellpoint team up to launch drug surveillance system

Patient Safety Monitor Alert, April 16, 2008

Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

The largest insurer in the U.S. is joining forces with the Food and Drug Administration to form a comprehensive drug surveillance system, reports The Wall Street Journal. Wellpoint will scan its database of 35 million customers periodically to search for spikes in medical problems over the past year. The FDA plans to follow this model to track medication issues throughout the country, using insurer information.

The aim for this system is to detect any medications that may be causing patients' problems. Analyzing claims and pharmacy data of its customers will enable Wellpoint to gain real-time knowledge of any patterns.

To read the story, click here.



Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!

Comments

0 comments on “FDA and Wellpoint team up to launch drug surveillance system

 

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles